- Home
- NATR vs CADL Comparison
NATR vs CADL Comparison
Compare NATR & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | CADL |
|---|---|---|
| Founded | 1972 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NATR | CADL |
|---|---|---|
| Price | $21.17 | $5.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $21.33 | $19.43 |
| AVG Volume (30 Days) | 182.3K | ★ 723.8K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $474,542,000.00 | N/A |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $26.24 | ★ N/A |
| Revenue Growth | ★ 6.62 | N/A |
| 52 Week Low | $11.01 | $4.25 |
| 52 Week High | $21.64 | $14.60 |
Technical Indicators
Market Signals| Indicator | NATR | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 67.20 | 58.58 |
| Support Level | $20.35 | $4.38 |
| Resistance Level | $21.46 | $4.87 |
| Average True Range (ATR) | 0.92 | 0.29 |
| MACD | -0.06 | 0.08 |
| Stochastic Oscillator | 79.74 | 93.81 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.